chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX261113C00010500
IBRX Nov 13 2026 10.50 Call
optionOPRA

EODOct 16, 2026
0.61USD-33.696%(-0.31)13Vol56OI
Loading…
Underlying
IBRX
Underlying Price
$8.33
Type
Call
Strike
10.5
Expiration
Nov 13, 2026
DTE
24d
Moneyness
OTM
Intrinsic
$0.00
IBRX 10.5 Call Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d$0.15-57.14%2271,476
Oct 30, 202610d$0.22-60.00%64472
Nov 6, 202617d$0.65-14.47%444
Nov 13, 202624d$0.61-33.70%1356
Nov 27, 202638d$0.85-39.29%6103
IBRX Nearby Strikes · Nov 13, 2026
StrikeLastChangeVolOpen IntMoneyness
7.5 C——00ITM
8 C——00ITM
8.5 C——00OTM
9 C$1.19-38.02%512OTM
9.5 C$0.88-39.73%214382OTM
10 C$0.70-40.68%938OTM
10.5 C$0.61-33.70%1356OTM
11 C$0.80-20.00%9441OTM
11.5 C$0.65+22.64%2225OTM
12 C$0.51-32.00%168213OTM
12.5 C$0.52+0.00%12OTM
13 C$0.43-18.87%88120OTM
13.5 C——00OTM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.